Variant report
Variant | nsv906934 |
---|---|
Chromosome Location | chr16:76021698-76069129 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs8057412 | chr16:76021698-76021699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554697512 | chr16:76021740-76021741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373300898 | chr16:76021753-76021754 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs72791354 | chr16:76021758-76021759 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs541324022 | chr16:76021779-76021780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs11866280 | chr16:76021788-76021789 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs150750786 | chr16:76021796-76021797 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543020542 | chr16:76021814-76021815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs76486899 | chr16:76021821-76021822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs137868656 | chr16:76021824-76021825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563097259 | chr16:76021875-76021876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs36049809 | chr16:76021878-76021879 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs559512873 | chr16:76021881-76021882 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191307932 | chr16:76021888-76021889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571862381 | chr16:76021894-76021895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149466358 | chr16:76021917-76021918 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111351917 | chr16:76021957-76021958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112373618 | chr16:76021964-76021965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147212892 | chr16:76021965-76021966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550685604 | chr16:76022034-76022035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567775019 | chr16:76022094-76022095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs548521361 | chr16:76022097-76022098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2866263 | chr16:76022102-76022103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs567378252 | chr16:76022104-76022105 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374041523 | chr16:76022110-76022111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370147758 | chr16:76022111-76022112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs555640911 | chr16:76022114-76022115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs576004406 | chr16:76022120-76022121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs200356274 | chr16:76022125-76022126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs61131960 | chr16:76022126-76022127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149238791 | chr16:76022129-76022130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs76294051 | chr16:76022148-76022149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368623866 | chr16:76022158-76022159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558102915 | chr16:76022172-76022173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182485313 | chr16:76022204-76022205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547676850 | chr16:76022217-76022218 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs374321747 | chr16:76022232-76022233 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs556681812 | chr16:76022235-76022236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs368187779 | chr16:76022250-76022251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs566177917 | chr16:76022264-76022265 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs573723024 | chr16:76022281-76022282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs140652547 | chr16:76022285-76022286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs534589091 | chr16:76022346-76022347 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs112943397 | chr16:76022350-76022351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187174522 | chr16:76022368-76022369 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs565272466 | chr16:76022387-76022388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs1909111 | chr16:76022393-76022394 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs75557076 | chr16:76022408-76022409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs550999466 | chr16:76022415-76022416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567542057 | chr16:76022423-76022424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Melanoma | 22183965 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 19156837 | CNVD |
Acute myeloid leukemia | 17377590 | CNVD |
Breast cancer | 20409316 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:76020000-76029600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr16:76029400-76030600 | Enhancers | Brain Germinal Matrix | brain |
3 | chr16:76029400-76032800 | Enhancers | HMEC | breast |
4 | chr16:76029600-76032400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr16:76032400-76049800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr16:76035600-76035800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr16:76037600-76038000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr16:76039200-76039400 | Enhancers | Brain Substantia Nigra | brain |
9 | chr16:76043200-76043400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr16:76049200-76051400 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr16:76051400-76055200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr16:76055200-76056400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr16:76055600-76055800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr16:76055800-76057400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
15 | chr16:76056400-76057600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr16:76057400-76057800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr16:76057600-76057800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr16:76057800-76058200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
19 | chr16:76058200-76058600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
20 | chr16:76061200-76061800 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
21 | chr16:76068200-76071000 | ZNF genes & repeats | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr16:76068800-76069400 | ZNF genes & repeats | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |